Barriers to Mental Healthcare Utilization in Parkinson's Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Parkinson's disease (PD) is the second most common neurodegenerative disorder in the elderly. In most people, the illness is complicated by co-occurring psychiatric problems such as depression and anxiety. These non-motor concerns negatively affect the course and management of the disease, often leading to poor outcomes for both patients and their families. Despite these deleterious consequences, psychiatric symptoms in PD are both underreported by patients as well as under-recognized and under-treated by health care providers.
The primary purpose of this study is to identify and describe barriers to mental healthcare utilization for people with Parkinson's disease. Secondary objectives include the assessment of attitudes and preferences regarding the need for mental health services in the PD community and the acceptability of telehealth interventions as a method for improving access and quality of care. In order to accomplish these aims, participants will be asked to fill out an anonymous survey which will take about 15-30 minutes to complete. To best accommodate PD patients with varying levels of disability, participants will have the option to complete the survey online, on paper, or over the phone. The information obtained from this study will be used to support future treatment development efforts (i.e., phone and internet based interventions, community based trainings with local providers) intended to improve access and quality of mental health care for people with PD. To the best of the investigators knowledge, this is the first study to systematically examine barriers to mental healthcare utilization in PD in a national sample.
| Condition | Intervention |
|---|---|
|
Parkinson's Disease Depression Anxiety |
Other: No Intervention. This is a cross-sectional survey study. |
| Study Type: | Observational |
| Study Design: | Observational Model: Ecologic or Community Time Perspective: Cross-Sectional |
| Official Title: | Barriers to Mental Healthcare Utilization in Parkinson's Disease |
- Survey [ Time Frame: 15 -30 minutes on one day ] [ Designated as safety issue: No ]The survey will assess several domains related to mental health care utilization. Participants will report demographic information. Subsequently, if applicable, they will answer questions pertaining to previous use of the mental healthcare system and barriers to future mental healthcare utilization. Attitudes and preferences regarding the need for mental health care services in the PD community, medical history, general healthcare utilization, and the acceptability of telehealth interventions as a method for improving access and quality of care will also be assessed.
| Enrollment: | 800 |
| Study Start Date: | June 2010 |
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| People with Parkinson's disease |
Other: No Intervention. This is a cross-sectional survey study.
No intervention.
|
Detailed Description:
The survey may be completed online at https://www.surveymonkey.com/s/improvecare4pd. Potential participants may also call Dr. Dobkin at 732-235-4051 to complete the survey over the phone or to request a paper copy to mailed out.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
People with Parkinson's disease.
Inclusion Criteria:
- Diagnosis of Parkinson's disease
- At least 18 years of age
Exclusion Criteria:
- Less than 18 years of age
We are looking for responses from those who have, as well as those who have not, had mental health treatment in the past.
Contacts and Locations| United States, New Jersey | |
| UMDNJ-Robert Wood Johnson Medical School | |
| Piscataway, New Jersey, United States, 08854 | |
| Principal Investigator: | Roseanne D Dobkin, PhD | University of Medicine and Dentistry New Jersey |
More Information
Additional Information:
No publications provided
| Responsible Party: | University of Medicine and Dentistry New Jersey |
| ClinicalTrials.gov Identifier: | NCT01167608 History of Changes |
| Other Study ID Numbers: | 0220100120, 1K23NS052155-01A2 |
| Study First Received: | July 20, 2010 |
| Last Updated: | September 27, 2012 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government |
Keywords provided by University of Medicine and Dentistry New Jersey:
|
Parkinson's disease Depression Anxiety Treatment |
Additional relevant MeSH terms:
|
Anxiety Disorders Depression Depressive Disorder Parkinson Disease Mental Disorders Behavioral Symptoms Mood Disorders |
Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |
ClinicalTrials.gov processed this record on May 21, 2013